FDA clears new vascular closure system

Editorial Staff | | Cardiovascular Business | Vascular & Endovascular

The FDA has granted Cardiva Medical's premarket approval for the Vascade vascular closure system (VCS).

The approval is based on clinical data from a prospective, multicenter, randomized 420-patient trial assessing the Vascade VCS as clinically and statistically superior in both safety and efficacy compared with manual compression, the gold standard for vascular closure for patients undergoing percutaneous procedures through the femoral artery.

Vascade, an extravascular closure device, utilizes a delivery system based on a collapsible disc technology that provides temporary hemostasis during the procedure. Hemostasis is achieved with Vascade by the deployment of a thrombogenic resorbable collagen patch at the arteriotomy of the femoral artery, according to the Sunnyvale, Calif.-based company.

Editorial Staff

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."